Sandra Guallar-Garrido

674 total citations · 2 hit papers
14 papers, 488 citations indexed

About

Sandra Guallar-Garrido is a scholar working on Surgery, Epidemiology and Immunology. According to data from OpenAlex, Sandra Guallar-Garrido has authored 14 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Sandra Guallar-Garrido's work include Bladder and Urothelial Cancer Treatments (7 papers), Mycobacterium research and diagnosis (4 papers) and Immune cells in cancer (3 papers). Sandra Guallar-Garrido is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Mycobacterium research and diagnosis (4 papers) and Immune cells in cancer (3 papers). Sandra Guallar-Garrido collaborates with scholars based in Spain, Switzerland and United States. Sandra Guallar-Garrido's co-authors include Esther Julián, Tania Patiño, Vanessa Gómez‐Vallejo, Pedro Ramos‐Cabrer, Ana C. Hortelão, Samuel Sánchez, Jordi Llop, Cristina Simó, Diana Vilela and Unai Cossío and has published in prestigious journals such as Nature Nanotechnology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Sandra Guallar-Garrido

13 papers receiving 486 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Swarming behavior and in vivo monitoring of enzymatic nanomotors within the bladder

2021 191 citations Ana C. Hortelão, Cristina Simó et al. Science Robotics profile →
Urease-powered nanobots for radionuclide bladder cancer therapy

2024 97 citations Cristina Simó, Ana C. Hortelão et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Guallar-Garrido Spain	7	225	225	101	92	82	14	488
Utkan Demirci United States	10	50 0.2×	338 1.5×	147 1.5×	30 0.3×	19 0.2×	14	546
Peng Ma China	7	91 0.4×	367 1.6×	340 3.4×	9 0.1×	22 0.3×	9	631
Yusuke Konishi Japan	10	83 0.4×	43 0.2×	204 2.0×	35 0.4×	44 0.5×	28	482
Daniel Kupor United States	9	96 0.4×	162 0.7×	71 0.7×	4 0.0×	81 1.0×	13	434
Bernd Wagner Germany	11	22 0.1×	89 0.4×	108 1.1×	12 0.1×	40 0.5×	16	435
Nikhil Mittal United States	11	50 0.2×	365 1.6×	297 2.9×	62 0.7×	4 0.0×	16	624
Mamta Chabria Switzerland	10	14 0.1×	209 0.9×	221 2.2×	163 1.8×	41 0.5×	12	589
Tzu-Hsuan Chang Taiwan	9	15 0.1×	58 0.3×	111 1.1×	18 0.2×	74 0.9×	14	392
Sreyan Chowdhury United States	4	16 0.1×	359 1.6×	234 2.3×	17 0.2×	81 1.0×	5	674
Ken Horiuchi Japan	8	51 0.2×	70 0.3×	181 1.8×	9 0.1×	378 4.6×	11	685

Countries citing papers authored by Sandra Guallar-Garrido

Since Specialization

Citations

This map shows the geographic impact of Sandra Guallar-Garrido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Guallar-Garrido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Guallar-Garrido more than expected).

Fields of papers citing papers by Sandra Guallar-Garrido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Guallar-Garrido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Guallar-Garrido. The network helps show where Sandra Guallar-Garrido may publish in the future.

Co-authorship network of co-authors of Sandra Guallar-Garrido

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Guallar-Garrido. A scholar is included among the top collaborators of Sandra Guallar-Garrido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Guallar-Garrido. Sandra Guallar-Garrido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Simó, Cristina, Ana C. Hortelão, Valerio Di Carlo, et al.. (2024). Urease-powered nanobots for radionuclide bladder cancer therapy. Nature Nanotechnology. 19(4). 554–564. 97 indexed citations breakdown →

Guallar-Garrido, Sandra & Thierry Soldati. (2024). Exploring host–pathogen interactions in the Dictyostelium discoideum–Mycobacterium marinum infection model of tuberculosis. Disease Models & Mechanisms. 17(7). 6 indexed citations

Guallar-Garrido, Sandra, Míriam Pérez‐Trujillo, Cecilia Cabrera, et al.. (2022). Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-gamma/IL-17 release in bladder cancer treatment. Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona). 3 indexed citations

Senserrich, Jordi, Sandra Guallar-Garrido, Víctor Urrea, et al.. (2022). Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition. Frontiers in Immunology. 13. 993401–993401. 1 indexed citations

Guallar-Garrido, Sandra, et al.. (2022). The High Plasticity of Nonpathogenic Mycobacterium brumae Induces Rapid Changes in Its Lipid Profile during Pellicle Maturation: The Potential of This Bacterium as a Versatile Cell Factory for Lipid Compounds of Therapeutic Interest. International Journal of Molecular Sciences. 23(21). 13609–13609. 2 indexed citations

Guallar-Garrido, Sandra, Marina Luquin, & Esther Julián. (2021). Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography. Journal of Visualized Experiments. 5 indexed citations

Hortelão, Ana C., Cristina Simó, Maria Guix, et al.. (2021). Swarming behavior and in vivo monitoring of enzymatic nanomotors within the bladder. Science Robotics. 6(52). 191 indexed citations breakdown →

Guallar-Garrido, Sandra, et al.. (2021). BCG Substrains Change Their Outermost Surface as a Function of Growth Media. Vaccines. 10(1). 40–40. 4 indexed citations

Guallar-Garrido, Sandra, Marina Luquin, & Esther Julián. (2021). Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography. Journal of Visualized Experiments.

10.

Guallar-Garrido, Sandra, et al.. (2020). Mycolicibacterium brumae is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment. Vaccines. 8(2). 198–198. 12 indexed citations

11.

Guallar-Garrido, Sandra, et al.. (2020). Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect. Microorganisms. 8(5). 734–734. 8 indexed citations

12.

Guallar-Garrido, Sandra & Esther Julián. (2020). <p>Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update</p>. ImmunoTargets and Therapy. Volume 9. 1–11. 137 indexed citations

13.

Noguera-Ortega, Estela, Sandra Guallar-Garrido, & Esther Julián. (2020). Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers. Cancers. 12(7). 1802–1802. 10 indexed citations

14.

Noguera-Ortega, Estela, Núria Blanco‐Cabra, Rosa M. Rabanal, et al.. (2016). Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment. Scientific Reports. 6(1). 27232–27232. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact